Biotech Mailbag: NeurogesX Patchy at Best

---

Lastly, a note about the Biotech Mailbag: This column has been a weekly fixture for the past two years, but in recent months my new workload on the Biotech Select newsletter has made it difficult for me to commit the time necessary to keep the Mailbag going with such frequency.

I really enjoy the interaction that comes from answering your emails, and I hope you're getting something out of my responses. But moving forward, I'll be writing the Mailbag on an every-two-week schedule. So, look for the next Mailbag on Dec. 19 and then every two weeks after that.